A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases” Monica Casiraghi, MD,

Slides:

Advertisements

Similar presentations

Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.

Advertisements

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD

Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids Piero Ferolla, MD, PhD, Niccolò Daddi, MD,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, MD, MSc, Ronald Feld, MD,

Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy Antonio Mazzella, MD, Alessandro Pardolesi,

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up Marco Lucchi, MD, Franca Melfi, MD, Paolo.

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer Ernest Nadal,

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program Giulia Veronesi, MD, Massimo Bellomi, MD,

Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Francesco Leo, MD, Piergiorgio Solli,

Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901 Stephen L. Graziano,

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids Piero Ferolla, MD, PhD, Niccolò Daddi, MD,

Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy Francesco Petrella, MD, Davide Radice,

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Surgery for oligometastatic non–small cell lung cancer: Long-term results from a single center experience Maria Teresa Congedo, MD, Alfredo Cesario,

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Use of indocyanine green to facilitate intersegmental plane identification during robotic anatomic segmentectomy Alessandro Pardolesi, MD, Giulia Veronesi,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

“Circular clamp” excision: A new technique for lung metastasectomy

Pulmonary Resection for Metastatic Gastric Cancer

Prognostic role of lymph node involvement in lung metastasectomy

Mediastinal-like growing teratoma syndrome

Giant Alveolar Adenoma Causing Severe Dyspnoea

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal.

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Clinical Outcomes and Prognosis of Recurrent Thymoma Management

High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid.

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Synchronous Primary Lung Cancer, Breast Cancer Recurrence, and Mediastinal Silicon- Induced Lymphadenitis Francesco Petrella, MD, Gian Carlo Pruneri,

Outcomes of Mediastinoscopy and Surgery with or without Neoadjuvant Therapy in Patients with Non-small Cell Lung Cancer Who are N2 Negative on Positron.

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Is surgery for multiple lung metastases reasonable

“Salvage” Surgery for Primary Mediastinal Malignancies: Is it Worthwhile? Francesco Petrella, MD, Francesco Leo, MD, PhD, Giulia Veronesi, MD, Piergiorgio.

The Number of Pulmonary Metastases: Influence on Practice and Outcome

Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy Yelena.

A Systematic Review of Restaging After Induction Therapy for Stage IIIa Lung Cancer: Prediction of Pathologic Stage Sara de Cabanyes Candela, MD, Frank.

Matthew Reichert, MD, Eric S. Bensadoun, MD

It’s All in the “Swerve of the Curve”

Pulmonary Metastasectomy in Breast Cancer

Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,

Pulmonary Resection for Metastases from Colorectal Cancer

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Features and Prognostic Factors of Large Node-Negative Non–Small-Cell Lung Cancers Shifted to Stage II Francesca Toffalorio, MD, PhD, Davide Radice,

Surgical Techniques and Long-Term Results of Pulmonary Artery Reconstruction in Patients With Lung Cancer Domenico Galetta, MD, PhD, Alessandro Borri,

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

The Development of an International Registry

Disease-Free Interval Length Correlates to Prognosis of Patients Who Underwent Metastasectomy for Esophageal Lung Metastases Satoshi Shiono, MD, Masafumi.

Four-arm robotic lobectomy for the treatment of early-stage lung cancer Giulia Veronesi, MD, Domenico Galetta, MD, Patrick Maisonneuve, DipEng, Franca.

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D

Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: Preliminary results Lorenzo Spaggiari, MD, PhD, Domenico Galetta,

Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006 Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.

Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.

Presentation transcript:

A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases” Monica Casiraghi, MD, Tommaso De Pas, MD, Patrick Maisonneuve, Eng., Daniela Brambilla, MSc, Barbara Ciprandi, MD, Domenico Galetta, MD, PhD, Alessandro Borri, MD, Roberto Gasparri, MD, Francesco Petrella, MD, Adele Tessitore, MD, Juliana Guarize, MD, Stefano Maria Donghi, MD, Giulia Veronesi, MD, Piergiorgio Solli, MD, Lorenzo Spaggiari, MD, PhD Journal of Thoracic Oncology Volume 6, Issue 8, Pages 1373-1378 (August 2011) DOI: 10.1097/JTO.0b013e3182208e58 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Overall survival for all patients (A) and according to completeness of pulmonary resection (B) after a mean follow-up of 34 months. Journal of Thoracic Oncology 2011 6, 1373-1378DOI: (10.1097/JTO.0b013e3182208e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Overall survival according to disease-free interval (A), lymph node involvement (B), histology (C), and epithelial tumors subtypes (D). Journal of Thoracic Oncology 2011 6, 1373-1378DOI: (10.1097/JTO.0b013e3182208e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Overall survival according to number of pulmonary metastasectomies after the last complete resection. Journal of Thoracic Oncology 2011 6, 1373-1378DOI: (10.1097/JTO.0b013e3182208e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Overall survival according to positron emission tomography (PET) (A) and chemotherapy (CT) (B). Journal of Thoracic Oncology 2011 6, 1373-1378DOI: (10.1097/JTO.0b013e3182208e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions